Neil Garton

675 total citations
12 papers, 231 citations indexed

About

Neil Garton is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Neil Garton has authored 12 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Immunology. Recurrent topics in Neil Garton's work include Ion Transport and Channel Regulation (3 papers), Click Chemistry and Applications (2 papers) and Ubiquitin and proteasome pathways (2 papers). Neil Garton is often cited by papers focused on Ion Transport and Channel Regulation (3 papers), Click Chemistry and Applications (2 papers) and Ubiquitin and proteasome pathways (2 papers). Neil Garton collaborates with scholars based in United Kingdom, Germany and United States. Neil Garton's co-authors include A. Naylor, Andrew K. Takle, Robert W. Ward, Vincent Bordas, Jason Witherington, Alessandra Gaiba, Brian P. Slingsby, David G. Smith, Rab K. Prinjha and Ana Badimon and has published in prestigious journals such as The Journal of Experimental Medicine, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Neil Garton

12 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Garton United Kingdom 7 119 102 27 19 16 12 231
Songfeng Lu United States 6 113 0.9× 103 1.0× 22 0.8× 9 0.5× 9 0.6× 7 244
Prashi Jain United States 13 180 1.5× 129 1.3× 22 0.8× 26 1.4× 11 0.7× 22 342
Marcel Scheepstra Netherlands 8 171 1.4× 81 0.8× 16 0.6× 15 0.8× 26 1.6× 11 263
Laura Depta Germany 7 187 1.6× 51 0.5× 13 0.5× 15 0.8× 17 1.1× 17 240
María I. Albarrán Spain 11 199 1.7× 122 1.2× 24 0.9× 35 1.8× 7 0.4× 14 304
Zhang‐Bao Xu United States 7 184 1.5× 92 0.9× 29 1.1× 26 1.4× 14 0.9× 8 287
Pascal Savy United Kingdom 8 141 1.2× 70 0.7× 9 0.3× 28 1.5× 8 0.5× 11 211
Russell C. Mauger United States 7 125 1.1× 94 0.9× 18 0.7× 5 0.3× 17 1.1× 9 244
Allison M. Roberts United States 7 269 2.3× 130 1.3× 15 0.6× 21 1.1× 10 0.6× 7 345
Tania Tahtouh France 5 225 1.9× 105 1.0× 44 1.6× 23 1.2× 4 0.3× 8 383

Countries citing papers authored by Neil Garton

Since Specialization
Citations

This map shows the geographic impact of Neil Garton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Garton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Garton more than expected).

Fields of papers citing papers by Neil Garton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Garton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Garton. The network helps show where Neil Garton may publish in the future.

Co-authorship network of co-authors of Neil Garton

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Garton. A scholar is included among the top collaborators of Neil Garton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Garton. Neil Garton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
James, David W., Lydia C. Powell, Neil Garton, et al.. (2023). Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells. Clinical Epigenetics. 15(1). 63–63. 4 indexed citations
2.
Garton, Neil, Michael D. Barker, Emma J. Jones, et al.. (2016). Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(19). 4606–4612. 8 indexed citations
3.
Joberty, Gérard, Markus Böesche, Jack A. Brown, et al.. (2016). Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical Proteomics. ACS Chemical Biology. 11(7). 2002–2010. 23 indexed citations
4.
Badimon, Ana, Uwe Schaefer, Pinar Ayata, et al.. (2015). Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice. The Journal of Experimental Medicine. 212(11). 1771–1781. 49 indexed citations
5.
Garton, Neil, et al.. (2009). Discovery of biaryl inhibitors of H+/K+ ATPase. Bioorganic & Medicinal Chemistry Letters. 20(3). 1049–1054. 8 indexed citations
6.
Bamford, Mark J., Emmanuel H. Demont, Richard L. Elliott, et al.. (2009). Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs). Bioorganic & Medicinal Chemistry Letters. 19(13). 3602–3606. 12 indexed citations
7.
Panchal, Terry, Mark J. Bamford, Emmanuel H. Demont, et al.. (2009). Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs). Bioorganic & Medicinal Chemistry Letters. 19(23). 6813–6817. 10 indexed citations
8.
Demont, Emmanuel H., et al.. (2008). Synthesis of Tetrasubstituted 2-Aryl-3-arylsulfonyl Pyrroles: Unexpected Regioselectivity in Directed ortho-Metallation Reactions. Synlett. 2008(2). 185–188. 1 indexed citations
9.
Garton, Neil, Robert W. Ward, & Royston C. B. Copley. (2007). Novel products arising from bisarylmaleimide synthesis. Tetrahedron Letters. 49(3). 523–525. 2 indexed citations
10.
Witherington, Jason, Vincent Bordas, Richard L. Elliott, et al.. (2006). Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 16(21). 5538–5541. 6 indexed citations
11.
Witherington, Jason, Vincent Bordas, Alessandra Gaiba, et al.. (2003). 6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorganic & Medicinal Chemistry Letters. 13(18). 3055–3057. 103 indexed citations
12.
Witherington, Jason, Vincent Bordas, Alessandra Gaiba, et al.. (2003). 6‐Aryl‐pyrazolo[3,4‐b]pyridines: Potent Inhibitors of Glycogen Synthase Kinase‐3 (GSK‐3).. ChemInform. 34(51). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Songfeng Lu Breakdown of academic impact, for papers by Prashi Jain Breakdown of academic impact, for papers by Marcel Scheepstra Breakdown of academic impact, for papers by Laura Depta Breakdown of academic impact, for papers by María I. Albarrán Breakdown of academic impact, for papers by Zhang‐Bao Xu Breakdown of academic impact, for papers by Pascal Savy Breakdown of academic impact, for papers by Russell C. Mauger Breakdown of academic impact, for papers by Allison M. Roberts Breakdown of academic impact, for papers by Tania Tahtouh
Rankless by CCL
2026